TradingView
hotshot123
Mar 19, 2019 5:03 AM

Heavy Volume in JAGX + Phase Trial Data Coming Soon Long

Jaguar Health, Inc.NASDAQ

Description

JAGX Showing Resistance At $0.50. Next Resistace Level is $0.61. A Move Upward Is Likely Due To The Stock Being Oversold and Phase Trial Data Expected Sometime Soon! Bullish.
More